AIM ImmunoTech Inc. Quarterly Entity Common Stock, Shares Outstanding from Q2 2011 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
AIM ImmunoTech Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2011 to Q3 2024.
  • AIM ImmunoTech Inc. Entity Common Stock, Shares Outstanding for the quarter ending November 11, 2024 was 63.7M shares, a 30.4% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 63.7M +14.9M +30.4% Nov 11, 2024 10-Q 2024-11-14
Q2 2024 57.1M +8.47M +17.4% Aug 12, 2024 10-Q 2024-08-14
Q1 2024 49.9M +1.49M +3.09% Mar 27, 2024 10-K 2024-04-01
Q3 2023 48.8M +759K +1.58% Nov 12, 2023 10-Q 2023-11-14
Q2 2023 48.7M +621K +1.29% Aug 11, 2023 10-Q 2023-08-14
Q1 2023 48.4M +413K +0.86% Mar 28, 2023 10-K 2023-03-31
Q3 2022 48.1M +234K +0.49% Nov 9, 2022 10-Q 2022-11-14
Q2 2022 48M +201K +0.42% Aug 11, 2022 10-Q 2022-08-15
Q1 2022 48M +162K +0.34% Mar 25, 2022 10-K 2022-03-31
Q3 2021 47.8M +7.16M +17.6% Nov 8, 2021 10-Q 2021-11-15
Q2 2021 47.8M +8.16M +20.6% Aug 11, 2021 10-Q 2021-08-16
Q1 2021 47.8M +20.2M +73.1% Mar 31, 2021 10-Q 2021-05-17
Q3 2020 40.7M +32.4M +392% Nov 11, 2020 10-Q 2020-11-12
Q2 2020 39.7M +37.4M +1620% Aug 13, 2020 10-Q 2020-08-14
Q1 2020 27.6M -34.7M -55.6% Mar 27, 2020 10-K 2020-03-30
Q3 2019 8.26M -39.9M -82.9% Nov 12, 2019 10-Q 2019-11-14
Q2 2019 2.31M -44.9M -95.1% Aug 1, 2019 10-Q 2019-08-14
Q1 2019 62.3M +16.1M +34.8% Mar 22, 2019 10-K 2019-04-01
Q3 2018 48.2M +16.4M +51.7% Nov 1, 2018 10-Q 2018-11-14
Q2 2018 47.2M +18.1M +62% Aug 7, 2018 10-Q 2018-08-14
Q1 2018 46.2M +20M +76.4% Mar 1, 2018 10-Q 2018-05-15
Q3 2017 31.8M +7.66M +31.8% Nov 1, 2017 10-Q 2017-11-14
Q2 2017 29.2M -220M -88.3% Aug 1, 2017 10-Q 2017-08-14
Q1 2017 26.2M -221M -89.4% Mar 10, 2017 10-K 2017-03-31
Q3 2016 24.1M -223M -90.3% Nov 1, 2016 10-Q 2016-11-14
Q2 2016 249M +2.05M +0.83% Aug 1, 2016 10-Q 2016-08-15
Q1 2016 248M +32.5M +15.1% Mar 28, 2016 10-K 2016-03-29
Q3 2015 248M +47.5M +23.7% Nov 1, 2015 10-Q 2015-11-16
Q2 2015 247M +56.9M +29.9% Aug 1, 2015 10-Q 2015-08-12
Q1 2015 215M +31.2M +17% Mar 1, 2015 10-K 2015-03-19
Q3 2014 200M +32.3M +19.3% Nov 1, 2014 10-Q 2014-11-07
Q2 2014 190M +22.6M +13.5% Aug 1, 2014 10-Q 2014-08-08
Q1 2014 184M +17.1M +10.2% Apr 25, 2014 10-Q 2014-05-09
Q3 2013 168M +16.7M +11% Nov 1, 2013 10-Q 2013-11-08
Q2 2013 167M +31.2M +22.9% Aug 1, 2013 10-Q 2013-08-09
Q1 2013 167M +31M +22.8% Mar 1, 2013 10-K 2013-03-18
Q3 2012 151M +15.4M +11.4% Nov 1, 2012 10-Q 2012-11-02
Q2 2012 136M +739K +0.55% Aug 1, 2012 10-Q 2012-08-08
Q1 2012 136M Mar 1, 2012 10-K 2012-03-14
Q3 2011 136M Nov 1, 2011 10-Q 2011-11-09
Q2 2011 135M Aug 1, 2011 10-Q 2011-08-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.